 I. Determine the dose of suramin in combination with paclitaxel TXT that results in suramin plasma concentrations approaching 10-50 uM over the duration, when TXT in the plasma is at therapeutically significant levels, in women with stage IIIB or IV breast cancer. Phase I II. Determine the objective response rate in patients treated with this regimen. Phase II 